A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.
暂无分享,去创建一个
Nicoletta Pellegrini | N. Pellegrini | D. Del Rio | A. J. Stewart | Daniele Del Rio | Amanda J Stewart | Amanda J. Stewart
[1] S. Jain,et al. Erythrocyte Membrane Lipid Peroxidation and Glycosylated Hemoglobin in Diabetes , 1989, Diabetes.
[2] M. Beksaç,et al. Correlation between plasma malondialdehyde and ceruloplasmin activity values in preeclamptic pregnancies. , 2001, Clinical biochemistry.
[3] J. Steghens,et al. Diaminonaphtalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum. , 2001, Free radical biology & medicine.
[4] Yu-jing Zhang,et al. Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. , 2002, Carcinogenesis.
[5] S. Shiesh,et al. Total antioxidant capacity and malondialdehyde in acute abdominal pain. , 2002, The American journal of emergency medicine.
[6] L. Graver,et al. Direct method for quantification of free malondialdehyde with high-performance capillary electrophoresis in biological samples. , 1997, Clinical chemistry.
[7] N. Day,et al. Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[8] S. Chirico,et al. High-performance liquid chromatography-based thiobarbituric acid tests. , 1994, Methods in enzymology.
[9] R. S. Sohal,et al. Mechanisms of aging: an appraisal of the oxidative stress hypothesis. , 2002, Free radical biology & medicine.
[10] J. Vertommen,et al. Oxidative stress status in patients with diabetes mellitus: relationship to diet , 2003, European Journal of Clinical Nutrition.
[11] S. Manoharan,et al. Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[12] K. G. Akbulut,et al. Daily variations of plasma malondialdehyde levels in patients with early breast cancer. , 2003, Cancer detection and prevention.
[13] B. Halliwell,et al. Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. , 1993, Free radical research communications.
[14] L. Marnett. Lipid peroxidation-DNA damage by malondialdehyde. , 1999, Mutation research.
[15] J. Nielsen,et al. Plasma malondialdehyde as biomarker for oxidative stress : reference interval and effects of life-style factors , 1996 .
[16] C. Stalikas,et al. Analysis of malondialdehyde in biological matrices by capillary gas chromatography with electron-capture detection and mass spectrometry. , 2001, Analytical biochemistry.
[17] P. Elsner,et al. Oxidative stress in malignant melanoma and non‐melanoma skin cancer , 2003, The British journal of dermatology.
[18] E. Frankel,et al. Formation of malonaldehyde from lipid oxidation products , 1983 .
[19] R. Ferrari,et al. Oxidative stress in cardiovascular disease: myth or fact? , 2003, Archives of biochemistry and biophysics.
[20] P. Mecocci,et al. Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity. , 2002, Free radical biology & medicine.
[21] I. Young,et al. Measurement of Malondialdehyde in Plasma by High Performance Liquid Chromatography with Fluorimetric Detection , 1991, Annals of clinical biochemistry.
[22] L. Marnett,et al. Development of a method for determination of the malondialdehyde-deoxyguanosine adduct in urine using liquid chromatography-tandem mass spectrometry. , 2003, Analytical biochemistry.
[23] V. Ord,et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[24] N. Pellegrini,et al. Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. , 2003, Clinical chemistry.
[25] J. Isenberg,et al. Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[26] Manfred S. Green,et al. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] D. Naidoo,et al. Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[28] C. Exley,et al. Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[29] H. Maral,et al. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. , 2002, Clinical biochemistry.
[30] K. Uchida. Role of reactive aldehyde in cardiovascular diseases. , 2000, Free radical biology & medicine.
[31] S. Auriola,et al. Mass spectrometric (HPLC/ESI--MS/MS) quantification of pyrimido[1,3-a]purin-10(3H)-one, a guanine adduct formed by reaction of malondialdehyde with DNA. , 1999, Journal of pharmaceutical and biomedical analysis.
[32] D. Slatter,et al. The importance of lipid-derived malondialdehyde in diabetes mellitus , 2000, Diabetologia.
[33] Y. Ozkan,et al. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients , 2001, Journal of clinical pharmacy and therapeutics.
[34] K. Yagi,et al. A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.
[35] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[36] M. Boaz,et al. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. , 1999, Kidney international.
[37] D. Ferguson,et al. Analysis of the malondialdehyde-2'-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry. , 1997, Chemical research in toxicology.
[38] T. Yoshioka,et al. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. , 1979, American journal of obstetrics and gynecology.
[39] Shawn D. Chase,et al. Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[40] N. Sucu,et al. Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. , 2002, Archives of medical research.
[41] A. Espinosa-Mansilla,et al. Kinetic behaviour of the malonaldehyde-thiobarbituric acid reaction. kinetic-fluorimetric determination of malonaldehyde in human serum , 1996 .
[42] J. Dyr,et al. Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[43] N. Ilhan,et al. The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia. , 2002, Clinical biochemistry.
[44] J. Langridge,et al. Mass spectrometric analysis of 2-deoxyribonucleoside and 2'-deoxyribonucleotide adducts with aldehydes derived from lipid peroxidation. , 1998, Rapid communications in mass spectrometry : RCM.
[45] R. Paroni,et al. Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry. , 2002, Clinical chemistry.
[46] Naim Uzun,et al. Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[47] L. Marnett,et al. Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Paroni,et al. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. , 1999, Analytical biochemistry.
[49] R. Bird,et al. Comparative studies on different methods of malonaldehyde determination. , 1984, Methods in enzymology.
[50] K. G. Akbulut,et al. Differential Effects of Pharmacological Doses of Melatonin on Malondialdehyde and Glutathione Levels in Young and Old Rats , 1999, Gerontology.
[51] W. Pryor,et al. Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. , 1975, The Journal of organic chemistry.
[52] L. Marnett,et al. Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay. , 1998, Carcinogenesis.
[53] M. Hecker,et al. On the mechanism of prostacyclin and thromboxane A2 biosynthesis. , 1989, The Journal of biological chemistry.
[54] J. Čermák,et al. Solid-phase extraction in malondialdehyde analysis. , 1997, Analytical biochemistry.
[55] K. Yoneyama,et al. Relationship between plasma malondialdehyde levels and adenosine deaminase activities in preeclampsia. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[56] J. Arnaud,et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. , 1991, Nephron.
[57] A. Carrascosa,et al. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. , 2003, Free radical biology & medicine.
[58] Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. , 1978 .
[59] K. Torén,et al. Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[60] J. Knight,et al. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. , 1988, Clinical chemistry.
[61] A. Federico,et al. Oxidative stress in viral and alcoholic hepatitis. , 2003, Free radical biology & medicine.
[62] M. Raftery,et al. Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[63] A. Zhitkovich,et al. Analysis of DNA-protein crosslinking activity of malondialdehyde in vitro. , 1999, Mutation research.
[64] L. Marnett,et al. Malondialdehyde, a Product of Lipid Peroxidation, Is Mutagenic in Human Cells* , 2003, Journal of Biological Chemistry.
[65] Wei-Chang Tseng,et al. Determination of Thiobarbituric Acid Adduct of Malondialdehyde Using On-line Microdialys is Coupled with High-Performance Liquid Chromatography , 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[66] N. Delibaş,et al. Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. , 2002, Clinical biochemistry.
[67] J. Kalaivani Sailaja,et al. Circulating lipid peroxidation and antioxidant status in cervical cancer patients: a case-control study. , 2002, Clinical biochemistry.
[68] L. Marnett,et al. Reaction of malondialdehyde-DNA adducts with hydrazines-development of a facile assay for quantification of malondialdehyde equivalents in DNA. , 2002, Chemical research in toxicology.
[69] D. Doerge,et al. An improved 32P-postlabeling/high-performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues. , 1998, Chemical research in toxicology.
[70] F. Karatas,et al. Determination of free malondialdehyde in human serum by high-performance liquid chromatography. , 2002, Analytical biochemistry.
[71] W. Wąsowicz,et al. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. , 1993, Clinical chemistry.
[72] S. Taysı,et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. , 2002, Japanese journal of clinical oncology.